Wen-Fei Li

9PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 01, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.

|Mar 06, 2026
Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials.

Sai-Wei Huang, Ye-Lin Liang, Ya-Lan Tao

|Feb 19, 2025
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial.

Ling-Long Tang, Lin Chen, Gui-Qiong Xu

|Jun 06, 2023
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment.

Jiawei Lv, Yuan Wei, Jian-Hua Yin

|Jul 13, 2022
Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity-modulated radiotherapy.

Xiao-Tang Xiao, Yi-Shan Wu, Yu-Pei Chen

|Jun 16, 2022
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.

Yuan Zhang, Lei Chen, Guo-Qing Hu

Pageof 2

Frequent Collaborators

9 joint publications

Jun Ma

7 joint publications

Ling-Long Tang

5 joint publications

Na Liu

5 joint publications

Ying Sun